The U.S. Food and Drug Administration announced last week that a pharmaceutical company is removing a fentanyl patch from ...

Application of a multi-stacked fentanyl patch could result in serious, life-threatening, or fatal respiratory depression.

Alvogen has issued a nationwide recall of one lot of Fentanyl Transdermal System 25 patches because the patches may stick ...

first-time fentanyl patch recipients, children, and older adults may potentially be at greater risk of adverse events. The Company requests that patients immediately remove any patches in use that ...

Alvogen is advising patients to immediately remove any patches in ... which recalled two lots of Fentanyl Transdermal System 12 mcg/h transdermal patches in April 2019 after discovering that ...

Our lead product under development is an abuse-deterrent fentanyl patch incorporating our AVERSA ... between our sales teams and authors to remove any pressure or influence on our analyses ...

Alvogen, Inc. is voluntarily recalling one lot of Fentanyl Transdermal System 25 mcg/h transdermal patches to the consumer level. The reason for the recall is that there is a potential that patches ...